UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Droms Strauss Advisors Inc. MO ADV

Droms Strauss Advisors Inc. MO ADV reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,645 shares of the healthcare conglomerate’s stock after selling 82 shares during the quarter. Droms Strauss Advisors Inc. MO ADV’s holdings in UnitedHealth Group were worth $832,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. M&T Bank Corp raised its holdings in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC raised its holdings in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its holdings in shares of UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new stake in shares of UnitedHealth Group during the third quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC raised its stake in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. 0.33% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $523.48 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business’s fifty day moving average price is $523.11 and its 200 day moving average price is $563.00.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the business posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.